SOM INNOVATION BIOTECH S L has a total of 46 patent applications. It decreased the IP activity by 91.0%. Its first patent ever was published in 2012. It filed its patents most often in United States, Australia and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals are GENOVATE BIOTECHNOLOGY CO LTD, AIRES PHARMACEUTICALS INC and STAYBLE THERAPEUTICS AB.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | Australia | 4 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | Brazil | 3 | |
#5 | Canada | 3 | |
#6 | China | 3 | |
#7 | Republic of Korea | 3 | |
#8 | Mexico | 3 | |
#9 | Singapore | 3 | |
#10 | WIPO (World Intellectual Property Organization) | 3 | |
#11 | Chile | 2 | |
#12 | Israel | 2 | |
#13 | Russian Federation | 2 | |
#14 | Hong Kong | 1 | |
#15 | New Zealand | 1 | |
#16 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Insa Boronat Raul | 20 |
#2 | Reig Bolano Nuria | 18 |
#3 | Centellas Casado Marc | 18 |
#4 | Insa Boronat Raúl | 17 |
#5 | Gavalda Batalla Nuria | 16 |
#6 | Gavaldà Batalla Núria | 8 |
#7 | Reig Bolaño Núria | 8 |
#8 | Nardi Ricart Anna | 8 |
#9 | Reig Bolaño Nuria | 8 |
#10 | Esteva Gras Santiago | 8 |
Publication | Filing date | Title |
---|---|---|
EP3275433A1 | Sustained release composition comprising micronized tolcapone | |
CA2915811A1 | Therapeutic agents for use in the prophylaxis and/or treatment of hyperkinetic movement disorders | |
NZ623267A | New therapy for transthyretin-associated amyloidosis |